European Journal of EpidemiologyNeurosciencePeer-reviewed journal article
The 100-plus Study of Dutch cognitively healthy centenarians: rationale, design and cohort description
Henne H. HolstegeiD, Nina BekeriD, Tjitske Dijkstra, Karlijn Pieterse, Elizabeth Wemmenhove, Kimja Schouten, Linette Thiessens, Debbie Horsten, Sterre Rechtuijt, Sietske A.M. SikkesiD, Frans W.A. van PoppeliD, Hanne E.J. Meijers-HeijboeriD, Marc HulsmaniD, Philip ScheltensiD
Abstract
RATIONALEAlthough the incidence of dementia increases exponentially with age, some individuals reach >100 years with fully retained cognitive abilities. To identify the characteristics associated with the escape or delay of cognitive decline, we initiated the 100-plus Study (www.100plus.nl).\n\nDESIGNThe 100-plus Study is an on-going prospective cohort study of Dutch centenarians who self-reported to be cognitively healthy, their first-degree family members and their respective partners. We collect demographics, life history, medical history, genealogy, neuropsychological data and blood samples. Centenarians are followed annually until death. PET-MRI scans and feces donation are optional. Almost 30% of the centenarians agreed to post-mortem brain donation.\n\nCOHORT DESCRIPTIONTo date (September 2018), 332 centenarians were included in the study. We analyzed demographic statistics of the first 300 centenarians (25% males) included in the cohort. Centenarians came from higher socio-economic classes and had higher levels of education compared to their birth cohort; alcohol consumption of centenarians was similar, and most males smoked during their lifetime. At baseline, the centenarians had a median MMSE score of 25 points (IQR: 22.0-27.5); the large majority lived independently, retained hearing and vision abilities and was independently mobile. Mortality was associated with cognitive functioning: centenarians with a baseline MMSE score [≥]26 and <26 points had a mortality percentage of respectively 17% and 42% per annual year in the second year after baseline (p=0.003). The cohort was 2.1-fold enriched with the neuroprotective APOE-{varepsilon}2 allele relative to 60-80 year-old population controls (p=4.8x10-7), APOE-{varepsilon}3 was unchanged and the APOE-{varepsilon}4 allele was 2.3-fold depleted (p=6.3x10-7).\n\nCONCLUSIONSComprehensive characterization of the 100-plus cohort of cognitively healthy centenarians might reveal protective factors that explain the physiology of long-term preserved cognitive health.
- Citations
- 91
- FWCI
- 5.67
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuropathology and cognitive performance in centenarians
Andrea B. Ganz, Nina Beker, … Henne H. Holstege·Acta Neuropathologica CommunicationsPeer-reviewed·Jul 23, 2018
- Increased Genetic Protection Against Alzheimer's Disease in Centenarians
Harold T. Bae, Zeyuan Song, … Paola Sebastiani B·GeroSciencePeer-reviewed·Jul 4, 2025
- Your Brain Doesn't Look a Day Past 70! Cross-Sectional Associations with Brain-Predicted Age in the Cognitively-Intact Oldest-Old
Mark K. Britton, Hannah Hoogerwoerd, … Joseph M. Gullett·GeroSciencePeer-reviewed·Dec 11, 2025
- Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population
Moeen Riaz, Aamira J. Huq, … Paul A Lacaze·Aging CellPeer-reviewed·May 26, 2021
- Evaluating the association of APOE genotype and cognitive resilience in SuperAgers
Alaina Durant, Shubhabrata Mukherjee, … Leslie S. Gaynor·medRxiv·Jan 7, 2025
- Global brain maintenance predicts well-preserved cognitive function: A pooled analysis of three longitudinal population-based Swedish cohorts
Saana M. Korkki, Justinas Narbutas, … Lars H Nyberg·Neurobiology of AgingPeer-reviewed·Jun 8, 2026